US FDA Focuses On Labs, Concomitant Medication To Avert Needless Clinical Trial Exclusions

 
• By Sarah Karlin-Smith
dozens of portraits of people to emphasize diversity
New FDA guidance aims to boost trial diversity with more inclusive trial eligibility criteria. • Source: Shutterstock

More from Clinical Trials

More from R&D